Resveratrol's antioxidant properties: dosage and does it really slow down aging

In 2003. A paper appears in Nature, according to which resveratrol activates sirtuins and extends the lifespan of yeast by 70 percent. The press turns this into an elixir of youth in a glass of red wine. Twenty years later, the picture looks different. Part of the effect in vitro turned out to be an artifact of the laboratory test, resveratrol did not extend the life of mice in a government testing program, and in humans, the free form of the compound is almost undetectable in the blood. The European Union allows it in supplements for adults at a maximum dose of 150 mg daily and requires warnings for those taking medications. Below you will find what remains of resveratrol after subtracting the marketing: where the evidence is decent, where it is lacking, and what is really worth checking before purchase.

KEY INFORMATION
• After a dose of 25 mg, at least 70 percent is absorbed, but the level of free resveratrol in the plasma is below 5 ng/ml (Walle et al., Drug Metab Dispos 2004).
• The EU allows trans-resveratrol in supplements for adults up to 150 mg per day (decision 2016/1190).
• A meta-analysis of 11 studies: improvement in glycemia only in people with diabetes (Liu et al., AJCN 2014).
• Preparat hamuje CYP3A4, CYP2D6 i CYP2C9 (Chow i in., 2010).
• In the analysis of 20 products from the market, 95 percent had a different content than declared (Bensa et al., Nutrients 2023).

What is resveratrol and where does it actually occur?

Resveratrol is a stilbenoid, a type of polyphenol that plants produce in response to fungal infection and UV radiation. The highest concentrations are found in the skin of dark grapes and Japanese knotweed (Polygonum cuspidatum), peanuts also contain a fair amount, as do some berries. Supplements almost always rely on an extract from knotweed.

The compound occurs in two spatial forms. The trans form is the one studied clinically and approved in the EU for sale as a novel food, while the cis form is produced under the influence of light and is significantly less researched. The EU specification for the approved ingredient requires a purity of no less than 99 percent.

The scale from diet and the scale from supplements are two different worlds. From food and wine, you provide single milligrams or fractions of them daily, while a capsule contains two to three orders of magnitude more. Almost all effects described in studies relate to supplemental doses.

We noticed while organizing this topic that most misunderstandings arise from mixing three levels of evidence: test tube, animal, and human. Resveratrol is a textbook example of a substance that looks spectacular at the first two levels and modestly at the third.

Why is the bioavailability of resveratrol so low?

Because absorption and bioavailability are not the same. After an oral dose of 25 mg, at least 70 percent is absorbed, but the level of unchanged resveratrol in the blood is below 5 ng/ml. The rest circulates as sulfates and glucuronides, which are derivatives with different biological activity.

This was established Walle i in. (2004, Drug Metabolism and Disposition) in six volunteers, administering isotopically labeled resveratrol. The peak concentration of the compound along with metabolites reached 491 ng/ml, the half-life in plasma was 9.2 hours, and the free form was practically absent. The authors indicated that the limiting step is the rapid conjugation with sulfate in the intestine and liver. Part of the dose is additionally hydrogenated by gut bacteria.

The consequence is more serious than it appears. Cell cultures usually operate at concentrations in the range of several dozen micromoles, while five nanograms per milliliter is about 0.02 micromoles, which is hundreds to thousands of times less. When you read that resveratrol inhibits a certain pathway in cancer cells, check at what concentration this was measured.

This is not saved by piperine, a compound from black pepper. In mice, adding piperine to resveratrol increased the area under the concentration curve to 229 percent of the baseline value, and the peak concentration to 1544 percent (Johnson i in., Molecular Nutrition and Food Research, 2011). In humans, this did not replicate: in a randomized pilot study, 24 volunteers received a single dose of 2.5 g of resveratrol with piperine at doses of 0, 5, or 25 mg, and no correlation between the piperine dose and pharmacokinetic parameters was found (Bailey i in., European Journal of Cancer Prevention, 2021). The same problem with absorption exists kurkumina and piperine has been studied there for years.

Does resveratrol really activate sirtuins?

This is a dispute, not a fact. Initial studies showed direct activation of SIRT1, but later tests with natural substrates did not confirm this. The effect appears when a fluorescent dye is attached to the test peptide and disappears when the dye is removed.

The starting point was a study Howitza i in. (2003, Nature), in which resveratrol lowered the Michaelis constant of SIRT1 against the acetylated substrate and NAD+, and extended the lifespan of yeast by 70 percent. Two years later Kaeberlein i in. (2005, Journal of Biological Chemistry) they demonstrated that activation is substrate-dependent: it occurs with peptides tagged with Fluor de Lys, while there is none with untagged peptides. In three strains of yeast, the authors also found no effect on Sir2 activity in the cell or on lifespan.

The resolution came in Pacholec i in. (2010, Journal of Biological Chemistry): neither resveratrol nor synthetic activators like SRT1720 stimulated SIRT1 when the substrate was a native peptide or full-length p53 protein. Using NMR and plasmon resonance methods, it was shown that the compounds bind directly to the peptide containing the fluorophore.

Indirect pathways, through AMPK and through the NAD+ pool, remain plausible. However, the simple version of the story, where a pill activates the longevity enzyme, did not survive laboratory verification.

Did resveratrol extend the lifespan of mammals?

In mice tested in the most rigorous available setup, it did not extend lifespan. In the Interventions Testing Program of the U.S. National Institute on Aging, it was administered to mice of mixed genetic background from the fourth month of life until death, in three independent centers simultaneously. There was no difference.

Strong i in. (2013, Journals of Gerontology Series A) they tested five substances in parallel: resveratrol, ekstrakt z zielonej herbaty, curcumin, oxalic acid, and medium-chain triglyceride oil. None of them had a statistically significant effect on the lifespan of males or females in the log-rank test. The program is designed to publish results regardless of whether they are favorable.

The same program previously showed an extension of mouse lifespan after rapamycin was administered starting from the 600th day of life, by 14 percent in females and 9 percent in males at an age corresponding to 90 percent mortality (Harrison i in., Nature, 2009). This is important when evaluating a negative result: the research system can detect an effect when it exists, so the lack of difference with resveratrol was not due to low test sensitivity.

So why were there reports of mice living longer? Earlier studies were usually conducted on animals on a high-fat diet, where resveratrol improved metabolic parameters in burdened animals. This is different from slowing down the aging process in a healthy organism.

How much resveratrol is in a glass of red wine?

On average about 0.3 mg. A review of analytical data from various regions gives 1.9 mg of trans-resveratrol per liter of red wine with a standard deviation of 1.7 mg, and record samples reach 14.3 mg per liter. A 150 ml glass thus contains a fraction of a milligram.

Let's calculate this to the end. To collect the EU limit for supplements from wine, which is 150 mg per day, at the average content one would need to drink about 520 glasses, close to 80 liters. Even if someone found wine at the upper end of the range, it would still amount to about 70 glasses a day. The data comes from a review Stervbo i in. (2007, Food Chemistry), which gathered published content on the resveratrol content in red wines. The highest concentrations were noted in the Pinot Noir and St. Laurent varieties, but no region proved to be distinctly better than the others.

The so-called French paradox, or the observation from the 1990s of low cardiovascular mortality in France despite a diet rich in saturated fats, was an epidemiological hypothesis, not an experiment. Wine consumption was associated with the entire Mediterranean pattern and a different lifestyle. Resveratrol entered this narrative as a candidate for explanation, never as a confirmed explanation.

What do meta-analyses of studies in humans show?

The effects are real, but narrow and dependent on whom is being studied. A meta-analysis of 11 randomized studies involving 388 participants showed a reduction in fasting glucose, insulin, glycated hemoglobin, and HOMA-IR index only in participants with diabetes. There was no effect in non-diabetic individuals.

Note the result regarding blood pressure. The effect was only visible in a subgroup, with a confidence interval covering a reduction from 2.81 to 20.99 mmHg and without confirmation in dose meta-regression, which is a premise for further research, not proof of efficacy.

Additionally, there is the purity of the literature. A proteomic analysis from 2006 on the cardioprotective effects of resveratrol was retracted in 2012 by the Journal of Cellular and Molecular Medicine., and the reason given was the fabrication of data found in the laboratory of Dipak K. Das, as demonstrated in proceedings by the University of Connecticut Health Center. Treat older texts referencing those results as outdated.

Is resveratrol safe and what does it interact with?

Short-term tolerance is good, but drug interactions are real and well-documented. In 42 healthy volunteers, 1 g daily for 4 weeks reduced the activity of three cytochrome P450 isoenzymes (CYP3A4, CYP2D6, CYP2C9), while increasing the activity of CYP1A2. A significant portion of chronically used drugs is metabolized by these isoenzymes.

Measurement was performed Chow i in. (2010, Cancer Prevention Research) using phenotypic methods, based on the metabolism rate of four reference substances: caffeine, dextromethorphan, losartan, and buspirone. The authors explicitly warn that pharmacological doses of resveratrol may increase the risk of adverse drug reactions when taken concurrently or alter their effectiveness. The legislator has drawn the conclusion: decyzja wykonawcza 2016/1190 it mandates that the label includes a warning that individuals taking medications may use the product only under medical supervision. The same principle of caution applies to the combination of herbs and plant extracts with each other..

Gastrointestinal disorders occur at high doses. In a study Brown i in. (2010, Cancer Research) forty volunteers took from 0.5 to 5 g daily for 29 days. The product was deemed safe, but doses of 2.5 g and 5 g caused mild to moderate gastrointestinal symptoms. The area under the curve for metabolites exceeded the values for resveratrol itself by up to twenty times.

Antiplatelet action has been described in vitro, on human platelets, at micromolar concentrations that the free form after a tablet does not reach. Therefore, the risk is more theoretical than measured. With anticoagulants, always report supplementation to your doctor, as interactions through cytochrome P450 directly concern this group.

What to pay attention to when choosing a supplement?

Whether the capsule contains what the label claims. In an analysis of 20 products from the Slovenian market, the content deviated from the declared in 95 percent of products, in 55 percent it was higher than stated, and in every fourth it exceeded the EU limit of 150 mg per day.

Badanie wykonali Bensa i in. (2023, Nutrients) using high-performance thin-layer chromatography with densitometry. The result changes the way to read the label: with such a large variance, the declared dose is a guideline, not a measurement. Therefore, check whether the manufacturer provides the trans form, standardization of the extract, and the batch testing result, not just the number of milligrams.

Doses found in the literature range from 100 mg to 5 g daily for periods from 4 weeks to about 3 months. These are research doses, designed to measure a specific endpoint, not a recommendation. In EU trade, trans-resveratrol is allowed only in capsules and tablets, exclusively for adults and no more than 150 mg daily.

Treat promises of increased bioavailability with caution. Liposomal and micronized forms and combinations with piperine are based on pharmacokinetic studies, mostly on animals, and a pilot randomized study in humans did not confirm the effect of piperine. A higher price does not automatically translate to a higher clinical effect.

Frequently Asked Questions

Does resveratrol slow down aging in humans?

There is no clinical evidence for this. Lifespan extension has been demonstrated in yeast, and in the Interventions Testing Program of the American National Institute on Aging, resveratrol administered to mice throughout their lives did not significantly affect their lifespan (Strong et al., 2013). No studies have been conducted in humans with lifespan as an endpoint.

How much resveratrol was used daily in studies?

The range in clinical trials is from 100 mg to 5 g daily, most often for 4 to 12 weeks. These are research doses, not recommendations. In EU circulation, a supplement with trans-resveratrol can provide a maximum of 150 mg daily and is intended solely for adults (executive decision 2016/1190).

Can a glass of wine replace a supplement with resveratrol?

No. Red wine contains an average of 1.9 mg of trans-resveratrol per liter, so a 150 ml glass provides about 0.3 mg (Stervbo et al., 2007). To reach the EU limit of 150 mg from wine, one would need to drink about 520 glasses, which is nearly 80 liters. Alcohol carries its own risks.

Does resveratrol interact with medications?

Yes. In 42 healthy volunteers, 1 g daily for 4 weeks reduced the activity of CYP3A4, CYP2D6, and CYP2C9, while increasing CYP1A2 (Chow et al., 2010). EU regulations require that the label informs that individuals taking medications should use the product only under medical supervision.

Is pterostilbene better than resveratrol?

It has better pharmacokinetics but a weaker research base in humans. In comparison in rats, at equimolar oral doses, the bioavailability of resveratrol was about 20 percent, while that of pterostilbene was about 80 percent (Kapetanovic i in., 2011). There are significantly fewer clinical studies with pterostilbene, so its advantage remains theoretical for now.

Does resveratrol lower cholesterol?

A meta-analysis of the dose-response relationship showed a reduction in total cholesterol of 10.28 mg/dl and LDL fraction of 5.69 mg/dl, with no changes in HDL (Cao et al., 2022). The reduction in LDL was more pronounced in studies lasting at least 12 weeks and in individuals with type 2 diabetes.

You won't find resveratrol with us at the moment, but if you're looking for other products to support your daily diet, check out the section supplements.

This article is for informational and educational purposes and does not constitute medical advice. Before starting supplementation, consult your doctor, especially if you are taking medications regularly, are pregnant or breastfeeding, or have a chronic illness.

Author: Michał Waluk · Opublikowano: 2026-06-08 · Aktualizacja: 2026-08-14